Windtree Therapeutics, Inc.
WINT
$1.20
-$0.10-7.69%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 60.90% | 53.46% | 83.06% | 48.25% | 41.70% |
| Total Depreciation and Amortization | 23.41% | 45.39% | 332.22% | 193.98% | 144.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -169.02% | -150.56% | -151.13% | -79.23% | -49.84% |
| Change in Net Operating Assets | 413.33% | 533.12% | 288.24% | 213.56% | 191.94% |
| Cash from Operations | -15.35% | 5.94% | 9.12% | 30.92% | 36.92% |
| Capital Expenditure | 20.00% | -- | -50.00% | -15.38% | 91.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 20.00% | -- | -107.50% | -107.61% | -162.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 1.28% | 35.48% | 31.27% | 32.11% | 24.07% |
| Issuance of Common Stock | -20.65% | -85.53% | 164.08% | 191.37% | 122.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.23% | -78.53% | 220.24% | 276.58% | 150.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -384.28% | -11,635.29% | 83.69% | 88.52% | 93.33% |
